Another study conducted by researchers at St Barnabas Medical Center in New Jersey and published on the medical website medRxiv concluded that hydroxychloroquine, a commonly used malaria drug, can increase a person’s chances of surviving COVID by 200%.
When U.S. President Donald Trump recommended the commonly used Malaria drug, hydroxychloroquine, back in April for the treatment of COVID-19, the mainstream media and left-wing politicians completely lost it. One politician even said she would charge Trump with crimes against humanity because of the recommendation.
Dr. Jane Orient is the executive director of the Association of American Physicians and Surgeons, and she recently responded to a study revealing that countries that allowed the controversial drug hydroxychloroquine (HCQ) to be used in the treatment of Covid had nearly a 75% lower death rate than those that didn’t.
Two more studies, one in Italy and the other out of the U.S., revealed that the controversial malaria drug, hydroxychloroquine, can reduce COVID deaths and even the risk of hospitalization.
Well, if you guessed, the controversial, mainstream-bashing malaria drug, hydroxychloroquine, you guessed right. Not only did New York City councillor Paul Vallone credit the drug for saving his life after he caught COVID, he even thanked President Donald Trump for recommending the treatment.
In early July, doctors, in one the largest slums in India, credited the controversial malaria drug Hydroxychloroquine for stopping a COVID outbreak dead in its tracks.
According to a Yale professor there is a political propaganda war being waged against hydroxychloroquine in its usage to combat the Coronavirus. The drug is commonly used medication to battle multiple issues including Malaria.
There has been a lot of controversy about using hydroxychloroquine, a common malaria drug, in the fight against COVID. As soon as US President Donald Trump recommended the drug, the mainstream media immediately opposed it.
A new study reveals that a common malaria and arthritis drug, hydroxychloroquine, is an effective tool in combating Covid-19. The study was undertaken by the Henry Ford Health System between March and May involving 2,541 patients. WND reports: While 26.4% of those who did not receive hydroxychloroquine died, only 13% of those who did get the drug died. The study was headlined, “Treatment with hydroxychloroquine cut death rate significantly in COVID-19 patients, Henry Ford Health System study shows.” The study published in the International Journal of Infectious Diseases said, “all patients in the study were 18 or over with a median age of 64 years; 51% were men and 56% African American.” The hospital attributed its high success rate to giving people the drug within 48 hours of admittance to their hospitals. Speaking on behalf of the hospital, Dr. Marcus Zervos said: “The findings have been highly analyzed and peer-reviewed.” “We attribute our findings that differ from other studies to early treatment, and part of a combination of interventions that were done in supportive care of patients, …
After President Donald Trump publicly stated in Mid-March that the malaria drug hydroxychloroquine could be an effective tool in fighting the coronavirus, the political backlash was immediate, with many of Trump’s political adversaries mocking the recommendation. Some even accused Trump of crimes against humanity for recommending the drug, that is routinely used as treatment for those with Malaria: I can’t take it anymore. I’ve been to The Hague. I’m making a referral for crimes against humanity tomorrow. Today’s press conference was the last straw. I know the need for a prosecution referral when I see one. https://t.co/XQin24gqY4 — Rep. Tavia Galonski (@RepGalonski) April 6, 2020 But there was some indication that the drug might be effective and several groups, including WHO, started testing the drug as a possible cure. But then…. On its face, it was a major finding: Antimalarial drugs touted by the White House as possible COVID-19 treatments looked to be not just ineffective, but downright deadly. A study published on 22 May in The Lancet used hospital records procured by a little-known …